TELIX PHARMACEUT (TLX): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in TLX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
2
13F filers
Aggregate Value
$2.3M
Across holders
Last Price
$11.01
2026-10-08
Sector
Health Care
GICS
Quarterly fund activity2 increased0 reduced1 exited
Full exits: Schonfeld Strategic Advisors LLC
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 189K | $2.2M | 94.9% | 0.0% | Added | — | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 10K | $118K | 5.1% | 0.0% | Added | — | Q2 2026 |
Loading recent insider activity…